Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(33): 1675
DOI: 10.1055/s-0031-1281574
DOI: 10.1055/s-0031-1281574
Pro & Contra | Commentary
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York
Können Biologika bei rheumatoider Arthritis nach Erreichen einer Remission abgesetzt werden? Contra
Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? NoFurther Information
Publication History
Publication Date:
10 August 2011 (online)
Schlüsselwörter
rheumatoide Arthritis - Biologika - Remission - Erhaltungstherapie
Keywords
rheumatoid arthritis - biologicals - remission - maintenance therapy
Literatur
- 1 Askling J. The risk of malignancies in RA patients treated with biologics. Z Rheumatol. 2010; 69 774-779
- 2 Braun J, Barraliakos X, Listing J. et al . Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis: evidence for different types of response over 5 years. Ann Rheum Dis. 2008; 67 340-345
- 3 Chatzidionysiou K, van Vollenhoven R F. When to initiate and discontinue biologic treatments for rheumatoid arthritis?. J Intern Med. 2011; 269 614-625
- 4 Saleem B, Keen H, Goeb V. et al . Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?. Ann Rheum Dis. 2010; 69 1636-1642
- 5 van den Broek M, Klarenbeek N B, Dirven L. et al . Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis. 2011; 70 1389-1394
Dr. Mathias Grünke
Oberarzt
Studienambulanz der Rheumaeinheit
Klinikum
der Universität München
Pettenkoferstr.
8a
80336 München
Phone: 089
5160 3473
Fax: +49 89 5160 3719
Email: Mathias.Gruenke@med.uni-muenchen.de